Loss of polymorphic A and B locus HLA antigens in colon carcinoma
- PMID: 3291922
- PMCID: PMC2246567
- DOI: 10.1038/bjc.1988.85
Loss of polymorphic A and B locus HLA antigens in colon carcinoma
Abstract
In the present study we have confirmed that approximately one third of human colorectal carcinomas fail to express the HLA - A,B,C monomorphic determinant reactive with the W6/32 MAb, and 44% express class II HLA antigens as shown by reactivity with NFK-1 MAb. Reduced staining with the W6/32 MAb was not always associated with the loss of beta 2m. In addition, the expression of HLA-A2 and Bw4 class I specific haplotypes on normal colon epithelium and tumour biopsy tissue was assessed. All normal colonic epithelia stained positively with MAb against A2 and Bw4 antigens, but a loss of these determinants was shown on tumour biopsies from patients tissue typed for the respective specificities. Loss of the A2 haplotype was shown in 4 of 15 tumour tissue samples, and loss of Bw4 specificities in 5 out of 7 tissue samples. The failure to detect specific loci determinants was not necessarily associated with loss of reactivity with W6/32 MAb.
Similar articles
-
Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.Br J Cancer. 1991 Nov;64(5):880-3. doi: 10.1038/bjc.1991.418. Br J Cancer. 1991. PMID: 1718386 Free PMC article.
-
HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.Br J Cancer. 1987 Feb;55(2):125-30. doi: 10.1038/bjc.1987.26. Br J Cancer. 1987. PMID: 3028461 Free PMC article.
-
Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.Br J Cancer. 1988 Apr;57(4):364-8. doi: 10.1038/bjc.1988.83. Br J Cancer. 1988. PMID: 2839218 Free PMC article.
-
Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.Lancet. 1988 Apr 9;1(8589):823-4. doi: 10.1016/s0140-6736(88)91682-0. Lancet. 1988. PMID: 2895339 No abstract available.
-
MHC antigen expression in colorectal tumours.Semin Cancer Biol. 1991 Feb;2(1):17-21. Semin Cancer Biol. 1991. PMID: 1912514 Review.
Cited by
-
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.Cell Mol Immunol. 2021 Mar;18(3):556-565. doi: 10.1038/s41423-021-00634-7. Epub 2021 Jan 20. Cell Mol Immunol. 2021. PMID: 33473191 Free PMC article. Review.
-
Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.Proc Natl Acad Sci U S A. 1989 Jul;86(14):5557-61. doi: 10.1073/pnas.86.14.5557. Proc Natl Acad Sci U S A. 1989. PMID: 2473473 Free PMC article.
-
Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas.Gut. 1996 Jan;38(1):85-9. doi: 10.1136/gut.38.1.85. Gut. 1996. PMID: 8566865 Free PMC article.
-
Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.Br J Cancer. 1990 Oct;62(4):603-6. doi: 10.1038/bjc.1990.338. Br J Cancer. 1990. PMID: 1699592 Free PMC article.
-
Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers.Cancers (Basel). 2022 Aug 16;14(16):3951. doi: 10.3390/cancers14163951. Cancers (Basel). 2022. PMID: 36010943 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials